Impel NeuroPharma

Impel NeuroPharma

Impel NeuroPharma is a Seattle-based company.

No article has been written about this topic yet.
Paste a URL about this topic to auto-extract knowledge.
Visit our Writing Guide for help on how to write about a topic,
and check out an example of a well filled out topic page.

No article has been written about this topic yet.
Be the first one to add some text.

Loading AI-assisted edit mode...

Timeline

December 7, 2018
Impel NeuroPharma raises a $67,500,000 series D round from KKR.
December 2018
Impel NeuroPharma raises a $67,500,000 series D round from venBio, 5AM Ventures, Vivo Capital, KKR and Norwest Venture Partners.
December 2, 2016
Impel NeuroPharma raises a $36,000,000 series C round from venBio.

Funding rounds

Funding round
Funding type
Funding round amount (USD)
Funding round date
Investment
Impel NeuroPharma funding round, December 2018
67,500,000
December 2018
3 Results
Results per page:
Page 1 of 1

People

Name
Role
LinkedIn

Chris Fuller

Employee

Gregg Bennett

Investor

Michael Hite

Employee

Paula Kim

Employee

Further reading

Title
Author
Link
Type
Date

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

News

Title
Author
Date
Publisher
Description
Impel NeuroPharma
November 9, 2020
www.prnewswire.com:443
/PRNewswire/ -- Impel NeuroPharma, a late-stage biopharmaceutical company, today announced that it has submitted a New Drug Application (NDA) for INP104...
June 10, 2020
BioSpace
Impel NeuroPharma Announces Primary Objectives Met In Pivotal Phase 3 Registration Study Of INP104 For The Treatment Of Acute Migraine - read this article along with other careers information, tips and advice on BioSpace
Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.